For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online
United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    Proteins and Peptides
    By product type
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex miRNA assays
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Customized Products & Partnerships
    Customized Products & Partnerships

    Customized products and commercial partnerships to accelerate your diagnostic and therapeutic programs.

    Customized products

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

  1. Link

    products/proteins-peptides/recombinant-human-alpha-synuclein-protein-aggregate-active-ab218819.pdf

  1. Send me a copy of this email
    I agree to the terms and conditions.
Neuroscience Neurology process Neurodegenerative disease Parkinson's disease Synuclein
Share by email

Recombinant Human Alpha-synuclein protein aggregate (Active) (ab218819)

  • Datasheet
Submit a review Submit a question References (2)

Product price, shipping and contact information

Currently unavailable

Sorry, we can't display this right now.

Please contact us to place your order, or try again later.

 

Loading size & price…

 

Shipping and order information

Shipping info

Promotion Information

Abpromise

Guaranteed product quality, expert customer support.

Find out more.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)
  • Functional Studies - Recombinant Human Alpha-synuclein protein aggregate (Active) (ab218819)
  • Electron Microscopy - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)
  • SDS-PAGE - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)
  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)
  • Electron Microscopy - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)
  • Electron Microscopy - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)
  • Functional Studies - Recombinant Human Alpha-synuclein protein aggregate (Active) (ab218819)
  • Electron Microscopy - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)

Key features and details

  • Expression system: Escherichia coli
  • Purity: > 95% SDS-PAGE
  • Endotoxin level: <= 20.000 Eu/ml
  • Active: Yes
  • Suitable for: WB, Functional Studies, SDS-PAGE

You may also be interested in

Protein
Product image
Recombinant Human Alpha-synuclein protein monomer (Active) (ab218818)
Protein
Product image
Recombinant human Tau (mutated P301S) protein aggregate (Active) (ab246003)
ELISA
Product image
Human Alpha-synuclein ELISA Kit (ab260052)

View more associated products

Description

  • Product name

    Recombinant Human Alpha-synuclein protein aggregate (Active)
    See all Alpha-synuclein proteins and peptides
  • Biological activity

    Endogenous alpha-synuclein phosphorylation.

    100 µM alpha synuclein protein monomer (ab218818) seeded with 10 µM alpha synuclein protein aggregate (ab218819) in 25 µM Thioflavin T (ab120751) (PBS pH 7.4, 100 µl reaction volume) generated a fluorescence intensity of 13,000 Relative Fluorescence Units after incubation at 37°C with shaking at 600 rpm for 24 hours.

    Fluorescence was measured by excitation at 450 nm and emission at 485 nm on a microplate reader.

    Endotoxin Level: 10-20 EU/mL

  • Purity

    > 95 % SDS-PAGE.
    ab218819 was purified by ion-exchange.
  • Endotoxin level

    <=20.000 Eu/ml
  • Expression system

    Escherichia coli
  • Accession

    P37840
  • Protein length

    Full length protein
  • Animal free

    No
  • Nature

    Recombinant
    • Species

      Human
    • Sequence

      MDVFMKGLSK AKEGVVAAAE KTKQGVAEAA GKTKEGVLYV GSKTKEGVVH GVATVAEKTK EQVTNVGGAV VTGVTAVAQK TVEGAGSIAA ATGFVKKDQL GKNEEGAPQE GILEDMPVDP DNEAYEMPSE EGYQDYEPEA
    • Predicted molecular weight

      14 kDa
    • Amino acids

      1 to 140
    • Additional sequence information

      (NP_000336.1) (GeneID 6622)
  • Description

    Recombinant human Alpha-synuclein protein (Active)

Associated products

  • Related Products

    • Thioflavin T, Fluorescent cell-permeable amyloid binding benzothiazole salt (ab120751)
    • Anti-Alpha-synuclein antibody [MJFR1] (ab138501)
    • Anti-Alpha-synuclein antibody [4D6] - BSA and Azide free (ab1903)
    • Recombinant Human Alpha-synuclein protein aggregate (Type 2) (ab218817)
    • Recombinant Human Alpha-synuclein protein monomer (Active) (ab218818)
    • Anti-Alpha-synuclein antibody [LB 509] (ab27766)

Specifications

Our Abpromise guarantee covers the use of ab218819 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Western blot

    Functional Studies

    SDS-PAGE

  • Form

    Liquid
  • Additional notes

    For best results, sonicate immediately prior to use. Sonication of PFFs is required in order to obtain fibrils with an average length of ~50nm, the optimal size for pathology.

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped on Dry Ice. Store at -80°C. Avoid freeze / thaw cycle.

    Constituent: 95% PBS

    This product is an active protein and may elicit a biological response in vivo, handle with caution.

General Info

  • Alternative names

    • Alpha synuclein
    • Alpha-synuclein
    • Alpha-synuclein, isoform NACP140
    • alphaSYN
    • MGC105443
    • MGC110988
    • MGC127560
    • MGC64356
    • NACP
    • Non A beta component of AD amyloid
    • Non A4 component of amyloid
    • Non A4 component of amyloid precursor
    • Non-A beta component of AD amyloid
    • Non-A-beta component of alzheimers disease amyloid , precursor of
    • Non-A4 component of amyloid precursor
    • Non-A4 component of amyloid, precursor of
    • OTTHUMP00000218549
    • OTTHUMP00000218551
    • OTTHUMP00000218552
    • OTTHUMP00000218553
    • OTTHUMP00000218554
    • PARK 1
    • PARK 4
    • PARK1
    • PARK4
    • Parkinson disease (autosomal dominant, Lewy body) 4
    • Parkinson disease familial 1
    • SNCA
    • Snca synuclein
    • Snca synuclein, alpha (non A4 component of amyloid precursor)
    • SYN
    • Synuclein alpha
    • Synuclein alpha 140
    • Synuclein, alpha (non A4 component of amyloid precursor)
    • SYUA_HUMAN
    see all
  • Function

    May be involved in the regulation of dopamine release and transport. Induces fibrillization of microtubule-associated protein tau. Reduces neuronal responsiveness to various apoptotic stimuli, leading to a decreased caspase-3 activation.
  • Tissue specificity

    Expressed principally in brain but is also expressed in low concentrations in all tissues examined except in liver. Concentrated in presynaptic nerve terminals.
  • Involvement in disease

    Genetic alterations of SNCA resulting in aberrant polymerization into fibrils, are associated with several neurodegenerative diseases (synucleinopathies). SNCA fibrillar aggregates represent the major non A-beta component of Alzheimer disease amyloid plaque, and a major component of Lewy body inclusions. They are also found within Lewy body (LB)-like intraneuronal inclusions, glial inclusions and axonal spheroids in neurodegeneration with brain iron accumulation type 1.
    Parkinson disease 1
    Parkinson disease 4
    Dementia Lewy body
  • Sequence similarities

    Belongs to the synuclein family.
  • Domain

    The 'non A-beta component of Alzheimer disease amyloid plaque' domain (NAC domain) is involved in fibrils formation. The middle hydrophobic region forms the core of the filaments. The C-terminus may regulate aggregation and determine the diameter of the filaments.
  • Post-translational
    modifications

    Phosphorylated, predominantly on serine residues. Phosphorylation by CK1 appears to occur on residues distinct from the residue phosphorylated by other kinases. Phosphorylation of Ser-129 is selective and extensive in synucleinopathy lesions. In vitro, phosphorylation at Ser-129 promoted insoluble fibril formation. Phosphorylated on Tyr-125 by a PTK2B-dependent pathway upon osmotic stress.
    Hallmark lesions of neurodegenerative synucleinopathies contain alpha-synuclein that is modified by nitration of tyrosine residues and possibly by dityrosine cross-linking to generated stable oligomers.
    Ubiquitinated. The predominant conjugate is the diubiquitinated form.
    Acetylation at Met-1 seems to be important for proper folding and native oligomeric structure.
  • Cellular localization

    Cytoplasm, cytosol. Membrane. Nucleus. Cell junction, synapse. Secreted. Membrane-bound in dopaminergic neurons.
  • Target information above from: UniProt accession P37840 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt

Images

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)

    Immunohistochemical analysis of primary rat hippocampal neurons showing lewy body inclusion formation when treated with active Alpha Synuclein Protein Aggregate (ab218819) at 4 µg/ml (D-F), but not when treated with control Alpha Synuclein Protein Aggregate (ab218817) at 4 µg/ml (A-C). Tissue: Primary hippocampal neurons. Species: Sprague-Dawley rat. Fixation: 4% formaldehyde from PFA. Primary antibody: Mouse anti-pSer129 Antibody at 1/1000 24 hours at 4°C. Secondary antibody: FITC Goat Anti-Mouse (green) at 1/700 for 1 hour at RT. Counterstain: Hoechst (blue) nuclear stain at 1/4000 for 1 hour at RT. Localization: Lewy body incluscions. Magnification: 20x.

  • Functional Studies - Recombinant Human Alpha-synuclein protein aggregate (Active) (ab218819)
    Functional Studies - Recombinant Human Alpha-synuclein protein aggregate (Active) (ab218819)

    ab218819 seeds the formation of new alpha synuclein fibrils from the pool of alpha synuclein monomers.

    Thioflavin T is a fluorescent dye that binds to beta sheet-rich structures, such as those in alpha synuclein fibrils. Upon binding, the emission spectrum of the dye experiences a red-shift, and increased fluorescence intensity.

    Thioflavin T emission curves show increased fluorescence (correlated to alpha synuclein protein aggregation) over time when 10 µM of ab218819 is combined with 100 µM of alpha synuclein monomer, as compared to ab218819 alone and alpha synuclein monomer alone.

    Thioflavin T ex = 450 nm, em = 485 nm.

  • Electron Microscopy - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)
    Electron Microscopy - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)

    TEM of active human alpha synuclein preformed fibrils (ab218819). Fibrils were sonicated and treated with uranyl acetate.

  • SDS-PAGE - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)
    SDS-PAGE - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)

    SDS-PAGE analysis of ab218819.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)

    Immunohistochemistry analysis of rat brain injected with active human alpha synuclein PFFs (ab218819). Species: Female Sprague-Dawley Rat. Rat was injected with 2µL active human alpha synuclein PFFs (ab218819) in each of 2 injection sites: AP+1.6, ML+2.4, DV-4.2 from skull; and AP-1.4, ML+0.2, DV-2.8 from skull. 30-days post-injection. Fixation: Saline perfusion followed by 4% PFA fixation for 48 hrs. Secondary Antibody: Biotin-SP Donkey Anti-Rabbit IgG (H+L) at 1:500 for 2 hours in cold room with shaking. ABC signal amplification, DAB staining. Alpha synuclein pathology is seen in the striatum close to an injection site.

  • Electron Microscopy - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)
    Electron Microscopy - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)

    TEM of ab218819.

  • Electron Microscopy - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)
    Electron Microscopy - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)

    TEM of active human alpha synuclein preformed fibrils (ab218819) (top) and control (inactive) human alpha synuclein preformed fibrils (ab218817) (bottom). Fibrils were sonicated and treated with uranyl acetate. The active fibrils are shorter than the inactive fibrils.

  • Functional Studies - Recombinant Human Alpha-synuclein protein aggregate (Active) (ab218819)
    Functional Studies - Recombinant Human Alpha-synuclein protein aggregate (Active) (ab218819)

    ThT emission curves show increased fluorescence (correlated to alpha-synucleinprotein aggregation) over time when 10 µM of active alpha-synuclein aggregate (ab218819) is combined with 100 µM of active alpha-synuclein monomer (ab218818) (light blue), as compared to when 100 µM of active alpha-synuclein monomer is combined with 10 µM of control alpha-synuclein aggregate (purple line), or 100 µM of control alpha-synuclein monomer (ab218816) is combined with 10 µM of control alpha-synuclein aggregate (ab218817) (dark blue). ThT ex = 450 nm, em = 485 nm. View protocol.

  • Electron Microscopy - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)
    Electron Microscopy - Recombinant human Alpha-synuclein protein aggregate (Active) (ab218819)

    TEM of active human alpha synuclein preformed fibrils (ab218819) (top) and control (inactive) human alpha synuclein preformed fibrils (ab218817) (bottom). Fibrils were sonicated and treated with uranyl acetate. The active fibrils are shorter than the inactive fibrils.

Protocols

To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.

Click here to view the general protocols

Datasheets and documents

  • Datasheet download

    Download

References (2)

Publishing research using ab218819? Please let us know so that we can cite the reference in this datasheet.

ab218819 has been referenced in 2 publications.

  • Piancone F  et al. Inflammatory Responses to Monomeric and Aggregated a-Synuclein in Peripheral Blood of Parkinson Disease Patients. Front Neurosci 15:639646 (2021). PubMed: 33867921
  • Baxter PS  et al. Targeted de-repression of neuronal Nrf2 inhibits a-synuclein accumulation. Cell Death Dis 12:218 (2021). PubMed: 33637689

Customer reviews and Q&As

Show All Reviews Q&A
Submit a review Submit a question

There are currently no Customer reviews or Questions for ab218819.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Get resources and offers direct to your inbox Sign up
A-Z by research area
  • Cancer
  • Cardiovascular
  • Cell biology
  • Developmental biology
  • Epigenetics & Nuclear signaling
  • Immunology
  • Metabolism
  • Microbiology
  • Neuroscience
  • Signal transduction
  • Stem cells
A-Z by product type
  • Primary antibodies
  • Secondary antibodies
  • Biochemicals
  • Isotype controls
  • Flow cytometry multi-color selector
  • Kits
  • Loading controls
  • Lysates
  • Peptides
  • Proteins
  • Slides
  • Tags and cell markers
  • Tools & Reagents
Help & support
  • Support
  • Make an Inquiry
  • Protocols & troubleshooting
  • Placing an order
  • RabMAb products
  • Biochemical product FAQs
  • Training
  • Browse by Target
Company
  • Corporate site
  • Investor relations
  • Company news
  • Careers
  • About us
  • Blog
Events
  • Tradeshows
  • Conferences
International websites
  • abcam.cn
  • abcam.co.jp

Join with us

  • LinkedIn
  • facebook
  • Twitter
  • YouTube
  • Terms of sale
  • Website terms of use
  • Cookie policy
  • Privacy policy
  • Legal
  • Modern slavery statement
© 1998-2023 Abcam plc. All rights reserved.